Mirae Asset Global Etfs Holdings Ltd. Standard Biotools Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Standard Biotools Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 176,271 shares of LAB stock, worth $188,609. This represents 0.0% of its overall portfolio holdings.
Number of Shares
176,271
Previous 168,777
4.44%
Holding current value
$188,609
Previous $295,000
35.59%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding LAB
# of Institutions
151Shares Held
280MCall Options Held
6KPut Options Held
36.6K-
Casdin Capital, LLC New York, NY76.1MShares$81.4 Million9.61% of portfolio
-
Viking Global Investors LP58.7MShares$62.8 Million0.21% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$23.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.2MShares$18.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY10.7MShares$11.5 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $84.2M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...